Although the specific gene responsible for cystic fibrosis (CF), CFTR, has been known for almost 20 years, the failure of CFTR–/– mice to develop human-like CF symptoms has limited the use of this animal model. In order to create an animal model that more closely represents human CF, researchers created transgenic CFTR–/– domestic pigs using tools and methods of mouse genetic manipulation. As with newborn humans, newborn pigs lacking CFTR initially showed no signs of disease. However, within a few days after birth they developed severe symptoms similar to the clinical manifestations of human CF. These symptoms included intestinal blockage (meconium ileus), exocrine pancreatic insufficiency and damage, and liver disease (focal biliary cirrhosis). Respiratory symptoms and lung disease are the primary causes of human CF mortality and morbidity, but symptom onset does not take place immediately; patients begin developing symptoms anywhere between 3 months to several years after birth. Similar to human neonates, the CFTR–/– piglets do not have obvious lung abnormalities at birth, but analyzing CFTR–/– pigs later in life might reveal progressive lung changes over time.
Cystic fibrosis: transgenic pigs mimic human symptoms
Cystic fibrosis: transgenic pigs mimic human symptoms. Dis Model Mech 21 November 2008; 1 (4-5): 185. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
A new call for papers is underway

Showcase your latest research in our upcoming special issue Translating Multiscale Research in Rare Disease, coordinated by DMM Editors Monica Justice, Karen Liu and Monkol Lek, and Guest Editor Kate Rauen. The deadline for submitting articles to the special issue is Monday 6 November 2023.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Crossroads in Virology

Our October Editorial written by Sumana Sanyal emphasises the urgency of a concerted effort in understanding virus–host interactions to inform the development of therapeutics and vaccines, helping to predict disease outcomes. Read the full Editorial here.
NOTCH signalling – a core regulator of bile duct disease?




In this Review, Anabel Martinez Lyons and Luke Boulter explore the concepts of NOTCH signalling reactivation in the biliary epithelium and how it is a reiterative and essential response to bile duct damage. Read the full Review Article here.
Other journals from
The Company of Biologists